TD Cowen analyst Joseph Thome maintained a Hold rating on PTC Therapeutics (PTCT – Research Report) today and set a price target of $60.00. The ...
UBS lowered the firm’s price target on Kyverna Therapeutics (KYTX) to $12 from $13 and keeps a Buy rating on the shares. The company reported ...
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...
LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...
Roche is to buy gene therapy firm Spark Therapeutics for $4.8 billion, adding an already-approved treatment for inherited blindness to its portfolio, and boosting its pipeline with a series of ...
Kyverna Therapeutics logo (PRNewsfoto/Kyverna Therapeutics) "Kyverna's first year as a public company was a transformative one, as we demonstrated our leadership position in autoimmune CAR T.
Christmas has come a few days early for Spark Therapeutics after the FDA approved its ground-breaking gene therapy for a rare eye disease. It looked likely that the FDA would approve the US ...
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. OpenAI has once again ignited a firestorm of controversy — this time, over ChatGPT ...
Watch the 1.0 and Console Release Date Announcement Trailer for Lynked: Banner of the Spark, an early access action-building roguelite RPG developed by FuzzyBot.
TechCrunch has been sold off by Yahoo and StubHub has filed for an IPO. Twitter's iconic bird logo that was removed from the ...
March 26, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the ...
If I were to ask readers to guess where they’d find the nation’s best K-12 public schools, they might not immediately think of the Defense Department’s educational system, but that would be ...